FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Discovery · preclinical Preparing its next products with a new combination-formulation technology and companion-animal drug development. Also seen: Commercial · sales

  • Announced a combination-formulation platform and plans for a product launch in 2027. Source

Roles often seen at this stageResearch & development · Manufacturing & MSAT

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Yuyu Pharma

A maker of prescription and over-the-counter medicines, newly developing a combination-formulation platform and new drugs for companion animals.

YUNICAP

Technology platform

Combination formulation joining soft capsules and pellets; a benign prostatic hyperplasia combination using it targets launch in the second half of 2027.

Cozal

Marketed

Nasal-care range that added three new products to make four.

Announced

Developed the YUNICAP combination-formulation platform and set up its manufacturing process at the Jecheon plant.

Official role guide

Yuyu Pharma careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 유유제약, 복합제형 기술 '유니캡' 개발···"내년 하반기 제품 출시" ↗뉴스웨이 · Published 2026-10-19 · Sources checked 2026-11-15 · Original unavailable
  2. 유유제약, '코잘' 4종 라인업 구축 ↗약사공론 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable